We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

8 hedge funds and large institutions have $135K invested in China Pharma Holdings in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

756% more capital invested

Capital invested by funds: $15.7K → $135K (+$119K)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

33% more funds holding

Funds holding: 6 → 8 (+2)

0.01% less ownership

Funds ownership: 0.51% → 0.5% (-0.01%)

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$78.5K
2
TSS
Two Sigma Securities
New York
+$24.9K
3
Jane Street
Jane Street
New York
+$9.68K
4
GSC
Ground Swell Capital
South Carolina
+$7.4K
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.53K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$608

CPHI Hedge Fund Activity: Q2 2026 in Review

8 of the 8,286 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2026, worth a combined $135K — up 756% from $15.7K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPHI positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $78.5K. The largest seller was Citigroup, exiting entirely with an estimated $608 sold.

  • 8 institutional investors held China Pharma Holdings (CPHI) as of Q2 2026, up from 6 in Q1 2026.
  • Funds reported $135K of China Pharma Holdings stock for Q2 2026, up 756% quarter-over-quarter.
  • 3 funds opened new China Pharma Holdings positions in Q2 2026 and 1 closed out, a net change of +2 holders.
  • The largest China Pharma Holdings buyer in Q2 2026 was Citadel Advisors, an estimated $78.5K added.
  • The largest China Pharma Holdings seller in Q2 2026 was Citigroup, an estimated $608 sold.

Based on aggregated 13F filings for Q2 2026.